KEY HIGHLIGHTS First patient expected to start therapy by end of Q2-2025 in Phase 2a proof-of concept clinical trial for ...

In 2019, the drug was approved to reduce the risk of hospitalisation for heart failure in patients with type 2 diabetes and earlier this year, Forxiga got the thumbs up for chronic kidney disease.

Chronic kidney disease (CKD) is among the fastest-growing noncommunicable ... According to one study, the incidence of drug-induced kidney damage (called nephrotoxicity) in older people may be as high ...

Pharma major Lupin Ltd on Thursday said it has received approval from the US health regulator for its generic version of Tolvaptan tablets indicated for a certain type of kidney disease. The approval ...

New Delhi, Apr 24 (PTI) Pharma major Lupin Ltd on Thursday said it has received approval from the US health regulator for its generic version of Tolvaptan tablets indicated for a certain type of ...

Pharma major Lupin Ltd on Thursday said it has received approval from the US health regulator for its generic version of Tolvaptan tablets indicated for a certain type of kidney disease.

A comprehensive new review by researchers at the University of Kentucky sheds light on the intricate and damaging relationship between obesity and kidney disease. "Our review shows that the link ...

broken bones and kidney disease. The American research team, whose findings were published in the journal Neurology, say the study does not prove that acid reflux drugs cause dementia - it only ...

One of the most promising developments in recent years in drug discovery is induced proximity. This drug discovery process utilizes molecules to bring proteins together to create a desired protein ...

reduce the incidence of lung scarring or post-TB lung disease, and improve outcomes for patients with drug-resistant TB. Other Johns Hopkins researchers who contributed to this study include Mona ...

My husband got a call in the middle of the night while I was in an induced coma to prepare ... I was given a lifesaving drug to treat a possible rare disease — one of the 5% of rare diseases ...